On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Metabolic syndrome and type 2 diabetes
- Evolution of man
- Visceral adiposity is not new
- Other possible causes of increased obesity
- Risk of obesity
- Effect of obesity
- Variability of VAT among obese subjects
- The "metabolic syndrome"
- Metabolic syndrome: a critical reappraisal
- "Metabolic xyndrome"
- Events in pathogenesis of metabolic xyndrome
- How the metabolic xyndrome occurs
- Animal models
- Visceral and subcutaneous adiposity
- Animals at basal sorted by body fat
- "Overflow hypothesis"
- Sequelae of IIFD (isocaloric higher fat)
- Adipocyte size distribution - control diet
- Adipocyte size distribution - high fat diet
- Isoproterenol stimulated lipolysis - high fat diet
- Liver temporal primacy in insulin resistance
- Gene expression and visceral adiposity
- Visceral fat depot
- Visceral lipolysis is pulsatile
- Effect of beta3-blockade on FFA release
- What causes increased FFA release?
- Flux of FFA to the liver
- High fat diet
- Liver histology
- Hepatic and peripheral insulin resistance
- Peripheral insulin resistance
- Effect of first-phase insulin
- Slow endothelial transport of insulin
- Setup
- Insulin concentration vs. glucose utilization rate
- Insulin sensitivity
- Distribution of insulin with obesity
- Transendothelial insulin transport (TET)
- The development of the metabolic xyndrome
- Cause of hyperinsulinemia
- Results of a high fat diet-fed animal model
- The signal for compensatory hyperinsulinemia
- What is the signal for beta-cell compensation?
- 24-hr plasma profiling
- 24-hr insulin
- Effect of 6 weeks of fat feeding
- Insulin, glucose, FFA nocturnal measurements
- Elevated overnight FFA following a high fat diet
- Pathogenesis of the metabolic xyndrome
Topics Covered
- Metabolic syndrome and type 2 diabetes
- Risk and effect of obesity
- "Metabolic syndrome"
- Pathogenesis of the metabolic syndrome
- Visceral and subcutaneous adiposity in the fat-fed dog model
- "Overflow" hypothesis
- Control diet and high fat diet
- Visceral adiposity
- Hepatic and peripheral insulin resistance
- Distribution of insulin with obesity
- Transendothelial insulin transport (TET)
- Hyperinsulinemia
- Insulin resistance
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Bergman, R. (2007, December 1). Pathogenesis of the metabolic syndrome [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/VCWV1476.Export Citation (RIS)
Publication History
- Published on December 1, 2007
Financial Disclosures
- Prof. Richard Bergman has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.